Inositol for PCOS: What the Trials Actually Support (and Where the Evidence Is Mixed)

As an Amazon Associate, sci-supplements.com earns from qualifying purchases. Links in this article may be affiliate links.

Inositol, specifically myo-inositol, is one of the more genuinely evidence-backed supplements for PCOS (polycystic ovary syndrome) – but even here, the picture is more mixed than most women’s-health marketing suggests.

What the trials show for metabolic and ovulation outcomes

Multiple randomized controlled trials have investigated myo-inositol (typically around 4g/day, often paired with folic acid) in women with PCOS. Across these trials, myo-inositol supplementation has been associated with improvements in insulin resistance markers (HOMA-IR), lower insulin and testosterone levels, and improved ovulatory function in a meaningful number of trials. A 2025 meta-analysis focused on assisted reproductive technology outcomes found myo-inositol/D-chiro-inositol supplementation significantly increased clinical pregnancy rate and top-grade embryo rate in women with PCOS undergoing fertility treatment.

Where the evidence gets genuinely mixed

Not every outcome holds up equally well. A more recent, critical evaluation of the fertility literature notes that considering the modest findings from the largest placebo-controlled studies, myo-inositol supplementation is not currently recommended specifically for subfertile individuals with PCOS trying to conceive, and much of the supportive trial base is now considered outdated relative to current clinical guidelines. In other words: the metabolic and insulin-sensitivity evidence is more consistent than the direct fertility/pregnancy evidence, and these are often marketed as the same thing when they are not.

Combination approaches

Some of the more recent trials test myo-inositol against or alongside metformin, the standard first-line insulin-sensitizing medication for PCOS. A 2024 trial found a fixed-dose combination of metformin plus myo-inositol outperformed metformin alone on both insulin resistance and menstrual cycle regularity measures over 24 weeks – suggesting inositol may work best as an add-on to, rather than a replacement for, standard care in diagnosed PCOS.

Dosing used in trials

Most positive trials use 2-4g/day of myo-inositol, often in a 40:1 ratio with D-chiro-inositol (mirroring the natural ratio found in healthy ovarian tissue), typically alongside 400mcg folic acid.

FAQ

Does inositol help with PCOS weight loss?
The stronger evidence is for insulin sensitivity and ovulatory function rather than weight loss specifically as a primary outcome.

Can inositol replace metformin for PCOS?
Current trial evidence supports it as a complementary addition alongside standard care rather than a proven replacement – this should be a conversation with your doctor, not a self-directed swap.

Does inositol help women trying to conceive with PCOS?
The evidence here is more mixed than the metabolic evidence – recent critical reviews note it is not currently recommended as a fertility treatment for subfertile individuals based on the strongest available trials.

Sources

• Meta-analysis of myo-inositol/D-chiro-inositol on ART outcomes in PCOS (2025): PMC
• Critical review, “Myo-inositol in reproductive management of women with PCOS”: ScienceDirect
• Phase III trial of metformin plus myo-inositol vs. metformin alone in PCOS: PMC

This article is for educational purposes and is not medical advice. PCOS management should be guided by a doctor, particularly regarding fertility treatment decisions.